Navigation Links
Closing the science-to-policy gap in maternal and child health in Africa
Date:6/29/2010

In the third of five papers in the PLoS Medicine series on maternal, neonatal, and child health in sub-Saharan Africa, Sara Bennett and Freddie Ssengooba this week discuss the challenges of getting science into policy in Africa. Dr Bennett, from Johns Hopkins University in Baltimore USA, and Dr Ssengooba from Makerere University in Uganda argue that that the technical basis for improving maternal, newborn, and child health (MNCH) in sub-Saharan Africa is largely known, but too often policy and practice are not well informed by science. Developing better policy networks in MNCH, mainstreaming the use of science in maternal, neonatal, and child health, and investing in innovative approaches to develop and applying such science are key, the authors say.

The authors conclude that "as we apply what we already know, we should continue to build institutional and individual capacity for the local adaptation and indigenization of global MNCH evidence to national and sub-national contexts, resources, and constraints."


'/>"/>

Contact: Andrew Hyde
press@plos.org
44-122-346-3330
Public Library of Science
Source:Eurekalert

Page: 1

Related medicine news :

1. Labopharm announces closing of US$20 million public offering of units
2. Sinovac Announces Closing of Common Share Offering
3. Mental Health Advocates and Community Providers Support Allentown State Hospital Closing
4. Disclosing sexual abuse is critical
5. Anesiva Stockholders Approved Merger With Arcion Therapeutics but Merger Remains Contingent on Other Closing Conditions
6. Country action is needed for maternal and child health in Africa
7. Full reproductive and sexual health rights essential for maternal health goals
8. ADHD linked to low maternal education, lone parents and welfare benefits
9. Regional differences in C-section rate not a result of maternal request: UBC study
10. PeriGen Knowledge Summit to Address Issues in Maternal Healthcare
11. Demonstrated in vivo the transfer of maternal thyroid hormones to the fetus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... HealthPostures, the desk for standing designer ... stand solutions representative to the Minneapolis Home and Garden Show which is being held ... is garnering national attention is the Minneapolis Convention Center. , From its broad ...
(Date:2/22/2017)... ... February 22, 2017 , ... When it came time to ... in Georgia, PENETRON Specialty Products (PSP) provided the solution. January’s grand opening presented ... $51 million to purchase and renovate the 185,000 square-foot office complex, which was ...
(Date:2/22/2017)... ... February 22, 2017 , ... Stem cell therapy ... The technology is so cutting edge, in fact, the U.S. Food and Drug ... procedures. However, successful patient outcomes in certain clinical stem cell procedures have shown ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... certification exam and eligibility requirements effective with the April 2017 testing period. NACCM, ... , “The Care Manager Certified (CMC) exam is periodically re-calibrated to ensure ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... analytics to accurately understand each Medicare Advantage member’s risk, identify any gaps-in-coding, ... This new solution helps transform the HCC Risk Adjustment process from a ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 23, 2017 Persistence Market ... global market for intraoperative imaging, excerpts from which ... US$ 513.9 million. According to the report, the ... the grounds of increasing adoption of minimally-invasive surgeries ... diagnostic imaging for neurosurgeries. The world,s leading medical ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... Industry Forecast to 2025" report to their offering. ... The Global Cardiac Prosthetic ... 9.2% over the next decade to reach approximately $8.9 billion by ... forecasts for all the given segments on global as well as ...
(Date:2/23/2017)... 2017 MabVax Therapeutics Holdings, Inc ... company, announces that it has received notice from ... the initiation a Phase I clinical trial with ... MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s novel ... initiate the phase I clinical trial in patients ...
Breaking Medicine Technology: